Abstract:Significance: The choroid plexus (ChP) epithelial network displays diverse dynamics, including propagating calcium waves and individuated fluctuations in single cells. These rapid events underscore the possibility that ChP dynamics may reflect behaviorally relevant and clinically important changes in information processing and signaling. Optogenetic and chemogenetic tools provide spatiotemporally precise and sustained approaches for testing such dynamics in vivo. Here, we describe the feasibility of a novel combined opto- and chemogenetic tool, BioLuminescent-OptoGenetics (BL-OG), for the ChP in vivo. In the "LuMinOpsin" (LMO) BL-OG strategy, a luciferase is tethered to an adjacent optogenetic element. This molecule allows chemogenetic activation when the opsin is driven by light produced through luciferase binding a small molecule (luciferin) or by conventional optogenetic light sources and BL-OG report of activation through light production. Aim: To test the viability of BL-OG/LMO for ChP control. Approach: Using transgenic and Cre-directed targeting to the ChP, we expressed LMO3 (a Gaussia luciferase-VChR1 fusion), a highly effective construct in neural systems. In mice expressing LMO3 in ChP, we directly imaged BL light production following multiple routes of coelenterazine (CTZ: luciferin) administration using an implanted cannula system. We also used home-cage videography with Deep LabCut analysis to test for any impact of repeated CTZ administration on basic health and behavioral indices. Results: Multiple routes of CTZ administration drove BL photon production, including intracerebroventricular, intravenous, and intraperitoneal injection. Intravenous administration resulted in fast "flash" kinetics that diminished in seconds to minutes, and intraperitoneal administration resulted in slow rising activity that sustained hours. Mice showed no consistent impact of 1 week of intraperitoneal CTZ administration on weight, drinking, motor behavior, or sleep/wake cycles. Conclusions: BL-OG/LMO provides unique advantages for testing the role of ChP dynamics in biological processes.

Strength of Activation and Temporal Dynamics of BioLuminescent-Optogenetics in Response to Systemic Injections of the Luciferin

Strength of Activation and Temporal Dynamics of BioLuminescent-Optogenetics in Response to Systemic Injections of the Luciferin

BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo

Efficient opto- and chemogenetic control in a single molecule driven by FRET-modified bioluminescence

Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation

Optogenetic Engineering to Probe the Molecular Choreography of STIM1-mediated Cell Signaling

Bioluminescence as a functional tool for visualizing and controlling neuronal activity in vivo

Engineering luminopsins with improved coupling efficiencies

Photoactivation of LOV domains with chemiluminescence

Novel luciferase–opsin combinations for improved luminopsins

Coupling optogenetic stimulation with NanoLuc-based luminescence (BRET) Ca++ sensing

Bioluminescence Imaging of Potassium Ion Using a Sensory Luciferin and an Engineered Luciferase

Protocol to study oxygen dynamics in the in vivo mouse brain using bioluminescence microscopy

Cell-Free Optogenetic Gene Expression System

OPTO-BLUE: An Integrated Bidirectional Optogenetic Lentiviral Platform for Controlled Light-Induced Gene Expression

Recent advances in bioluminescent probes for neurobiology

Bioluminescent Genetically Encoded Glutamate Indicators for Molecular Imaging of Neuronal Activity

Optogenetics for light control of biological systems

Dynamic Multiplexed Control and Modeling of Optogenetic Systems Using the High-Throughput Optogenetic Platform, Lustro

A synthetic BRET-based optogenetic device for pulsatile transgene expression enabling glucose homeostasis in mice

An Ultra-Sensitive Step-Function Opsin for Minimally Invasive Optogenetic Stimulation in Mice and Macaques.